Option 2 but simply get swallowed up by one of the big boys. BRK no longer exists and hopefully the offer for shareholders is a decent one
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress